Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IMI PLC Director's Dealing 2019

Mar 29, 2019

5257_dirs_2019-03-29_e126b218-ce7f-43ba-977e-0ff9833cdb9c.html

Director's Dealing

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 5479U

IMI PLC

29 March 2019

29 March 2019

IMI PLC

(the "Company")

Notification of Transactions by Persons Discharging Managerial Responsibilities ("PDMRs") and Persons Closely Associated with them

This notification relates to transactions notified in accordance with the Market Abuse Regulation, further details below:

1. Details of the person discharging managerial responsibilities/ person closely associated
a) Name 1.   Daniel Shook

2.   Roy Twite

3.   Paul Roberts

4.   Jun Hu
2. Reason for the notification
a) Position/status 1.   Chief Financial Officer

2.   Chief Executive Designate

3.   Business Development Director

4.   Divisional Managing Director
b) Initial notification/ Amendment Initial Notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name IMI plc
b) LEI 2138002W9Q21PF751R30
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument



  Identification code
Ordinary Share 



GB00BGLP8L22
b) Nature of the transaction 1a.  Exercise of award in respect of 21,732 shares vesting under the IMI plc Incentive Plan (nil cost option). Sale of 10,235 shares to cover tax and dealing costs and 11,497 shares retained.

1b.  Exercise of Deferred Bonus Shares award in respect of 11,701 shares vesting under the IMI plc Incentive Plan (nil cost option). Sale of 5,511 shares to cover tax and dealing costs and 6,190 shares retained.

2.    Exercise of award in respect of 32,086 shares vesting under the IMI plc Incentive Plan (nil cost option). Sale of 15,111 shares to cover tax and dealing costs and 16,975 shares retained and transferred into spouse's name.

3a.  Exercise of award in respect of 13,321 shares vesting under the IMI plc Incentive Plan (nil cost option). Sale of 6,274 shares to cover tax and dealing costs and 7,047 shares retained.

3b.  Exercise of Deferred Bonus Shares award in respect of 8,596 shares vesting under the IMI plc Incentive Plan (nil cost option). Sale of 4,049 shares to cover tax and dealing costs and 4,547 shares retained.

4a.  Exercise of award in respect of 4,372 shares vesting under the IMI plc Incentive Plan (nil cost option). Sale of 965 shares to cover tax and dealing costs and 3,407 shares retained.

4b.  Exercise of Deferred Bonus Shares award in respect of 3,675 shares vesting under the IMI plc Incentive Plan (nil cost option). Sale of 762 shares to cover tax and dealing costs and 2,913 shares retained.
c) Price(s) and volume(s) Price(s) Volume(s)
1a.   £9.42

1b.   £9.42

2.     £9.42

3a.   £9.42

3b.   £9.42

4a.   £9.42

4b.   £9.42
10,235

5,511

15,111

6,274

4,049

965

762
d) Aggregated information

·      Aggregated volume

·      Price
N/A individual transactions
e) Date of the transaction 28 March 2019
f) Place of the transaction London Stock Exchange Main Market (XLON)

For further information, please contact:

John O'Shea

Group Legal Director and Company Secretary

Telephone: 0121 717 3700

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

DSHSEWFIUFUSEID